Molbio Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 ,inter alia, to consider and approve To consider and approve ....

Date: September 01, 2026 To To BSE Limited (‘BSE’) National Stock Exchange of India Ltd Listing Department Exchange Plaza, Corporate Relationship Department B a n d r a - K u rla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai 400 051 2nd Floor, Dalal Street, Symbol: MOLBIO Mumbai – 400 001 BSE Script Code: 544866 Subject: Intimation of Board Meeting. Dear Sir/Madam, Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, September 05, 2026 inter-alia, to consider the following items of business: 1. To consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2026. 2. To consider any other matter with the permission of the Chair. Further, as already informed vide our letter dated 20th August 2026, the trading window for dealing in shares of the Company will continue to remain closed from 21st August 2026 till the expiry of 48 (Forty-Eight) hours from the date the approval of said Unaudited Standalone and Consolidated Financial Results for the quarter ended on June 30, 2026. This intimation is also available on the Company’s website at www.molbiodiagnostics.com in compliance with Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to kindly take the same on record. Thanking You. Yours Faithfully, For Molbio Diagnostics Limited Darshan Raghunath Karekar Company Secretary & Compliance Officer M. No: F13569 Place: Verna-Goa